CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SensApp focuses on creating a non-invasive sensor for early detection of Alzheimer's disease biomarkers in blood plasma. By employing an innovative droplet technology, it aims to enhance the sensitivity of biomarker detection, making it feasible for routine clinical use without the need for invasive procedures.
The detection of biomarkers in body fluids is of great importance for disease early diagnosis.
The clinical practice uses typically immunoassay methods (e.g. ELISA, Enzyme-Linked Immuno Sorbent Assay, and related techniques) for biomarker determination.
Unfortunately, these techniques fail dramatically in a wide variety of cases where the concentration of biomarkers falls below the limit of detection (LOD).
The Alzheimer’s disease (AD) is one real example.
Nowadays the AD diagnosis from blood co…
CONSIGLIO NAZIONALE DELLE RICERCHE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Bruxelles / Brussel
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
JOHANNES KEPLER UNIVERSITAT LINZ UNIVERSITY OF LINZ JOHANNES KEPLER UNIVERSITY OF LINZ JKU
Austria, Linz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
